Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)

NCT06294600 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Community-acquired Pneumonia

Interventions

DRUG: Clarithromycin 500mg
DRUG: Tablets

Sponsor

Hellenic Institute for the Study of Sepsis